Overall market sentiment has been neutral on New Frontier Health Corp (NFH) stock lately. NFH receives a Neutral rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With NFH Stock Today?
New Frontier Health Corp (NFH) stock is trading at $11.15 as of 1:43 PM on Friday, Feb 26, a gain of $0.03, or 0.27% from the previous closing price of $11.12. Volume today is 300,528 compared to average volume of 382,344. The stock has traded between $11.05 and $11.20 so far today.
More About New Frontier Health Corp
New Frontier Health Corp is a leading comprehensive private medical service platform. Through its subsidiary, it provides healthcare services throughout the life cycle in China. The firm's operating segments are Operating assets Tier 1, and Operating assets Tier 2 and other assets and Expansion assets. Tier 1 segment consists of the group's existing general hospitals and clinics located in tier 1 cities in China, such as Beijing and Shanghai whereas, tier 2 and other assets segment consists of the group's existing general hospitals and clinics located in tier 2 cities in China, such as Tianjin and Qingdao, and specialized healthcare facilities. The company generates a majority of its revenue from the Tier 1 segment.